APPLICATION
ANDA040707
TYPE
ANDA
ORIGINAL APPROVAL
2007-02-27
LATEST ACTION
2020-08-20
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription
Products
HYDROCHLOROTHIAZIDEPrescription
HYDROCHLOROTHIAZIDE 12.5MG · TABLET · ORAL
Approval history
2020-08-20Labeling · Supplement 17 · standardAP
2007-09-16Manufacturing (CMC) · Supplement 1AP
2007-02-27OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.